Livesey Tayah C, Mahmoud Lila A M, Katsikogianni Maria G, Nayak Sanjit
School of Chemistry and Biosciences, University of Bradford, Bradford BD7 1DP, UK.
School of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.
Pharmaceutics. 2023 Jan 12;15(1):274. doi: 10.3390/pharmaceutics15010274.
Antimicrobial resistance (AMR) is a growing global crisis with an increasing number of untreatable or exceedingly difficult-to-treat bacterial infections, due to their growing resistance to existing drugs. It is predicted that AMR will be the leading cause of death by 2050. In addition to ongoing efforts on preventive strategies and infection control, there is ongoing research towards the development of novel vaccines, antimicrobial agents, and optimised diagnostic practices to address AMR. However, developing new therapeutic agents and medicines can be a lengthy process. Therefore, there is a parallel ongoing worldwide effort to develop materials for optimised drug delivery to improve efficacy and minimise AMR. Examples of such materials include functionalisation of surfaces so that they can become self-disinfecting or non-fouling, and the development of nanoparticles with promising antimicrobial properties attributed to their ability to damage numerous essential components of pathogens. A relatively new class of materials, metal-organic frameworks (MOFs), is also being investigated for their ability to act as carriers of antimicrobial agents, because of their ultrahigh porosity and modular structures, which can be engineered to control the delivery mechanism of loaded drugs. Biodegradable polymers have also been found to show promising applications as antimicrobial carriers; and, recently, several studies have been reported on delivery of antimicrobial drugs using composites of MOF and biodegradable polymers. This review article reflects on MOFs and polymer-MOF composites, as carriers and delivery agents of antimicrobial drugs, that have been studied recently, and provides an overview of the state of the art in this highly topical area of research.
抗菌耐药性(AMR)是一个日益严重的全球危机,由于细菌对现有药物的耐药性不断增强,越来越多的细菌感染变得无法治疗或极难治疗。据预测,到2050年,抗菌耐药性将成为主要死因。除了在预防策略和感染控制方面持续努力外,目前还在开展研究,以开发新型疫苗、抗菌剂和优化的诊断方法来应对抗菌耐药性。然而,开发新的治疗药物可能是一个漫长的过程。因此,全球正在并行开展一项努力,开发用于优化药物递送的材料,以提高疗效并尽量减少抗菌耐药性。这类材料的例子包括对表面进行功能化处理,使其能够自我消毒或防污,以及开发具有良好抗菌性能的纳米颗粒,这归因于它们能够破坏病原体的许多重要成分。一类相对较新的材料,即金属有机框架(MOF),也因其作为抗菌剂载体的能力而受到研究,因为它们具有超高的孔隙率和模块化结构,可以进行设计以控制负载药物的递送机制。生物可降解聚合物也被发现作为抗菌载体具有良好的应用前景;最近,已有几项关于使用MOF与生物可降解聚合物的复合材料递送抗菌药物的研究报道。这篇综述文章反思了最近作为抗菌药物载体和递送剂进行研究的MOF和聚合物-MOF复合材料,并概述了这一热门研究领域的最新进展。